| Report ID | 282805 |
| Drug Identification Number | 01977547 |
| Brand name | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP |
| Common or Proper name | DEXAMTHASONE SODIUM PHOSPHATE INJECTION, USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION LIQUID |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRA-ARTICULAR INTRAVENOUS INTRAMUSCULAR INTRA-ARTICULAR |
| Packaging size | 10 VIALS |
| ATC code | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2026-04-10 |
| Estimated end date | 2026-09-14 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-04-13 |
| Company comments | Product is on 75% preventative allocation at McKesson. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-13 | French | Compare |
| v1 | 2026-04-13 | English | Compare |
Showing 1 to 2 of 2